Tranexamic acid Bleeding events can be controlled by platelet transfusion. Most heterozygotes, with few exceptions, do not have a bleeding diathesis. BSS presents as a bleeding disorder due to the inability of platelets to bind and aggregate at sites of vascular endothelial injury. In the event of an individual with mucosal bleeding tranexamic acid can be given. The affected individual may need to avoid contact sports and medications such as aspirin, which can increase the possibility of bleeding. A potential complication is the possibility of the individual producing anti-platelet antibodies.
Bernard–Soulier syndrome
Fryns-Aftimos syndrome
Harris platelet syndrome
Ehlers–Danlos syndromes
Quebec platelet disorder
Keutel syndrome
Von Willebrand disease
Flammer syndrome